4Vote!
MarketIntelligenceCenter.com (Free subscription) | yesterday
GlaxoSmithKline PLC (NYSE: GSK) closed yesterday at $41.47. So far the stock has hit a 52-week low of $27.15 and 52-week high of $42.98. GlaxoSmithKline PLC stock has been showing support around 40.92 and resistance in the 41.98 range. Technical indicators for the stock are Bullish and S&P gives GSK a neutral 3 STAR (out of 5) hold rating. GSK appears on the Investors Observer Volume Leaders list....
5Vote!
The Philadelphia Business Journal (Free subscription) | 11/30/2009
The Philadelphia Foundation said Monday that GlaxoSmithKline plc has established a $1 million college scholarship fund with it. (GSK)
4Vote!
USA Canoe/Kayak (Free subscription) | 11/30/2009
LONDON(AP) British drug maker GlaxoSmithKline PLC will provide anti-doping laboratory equipment to… Read
3Vote!
Forex Analytics (Free subscription) | 11/30/2009
GlaxoSmithKline plc (GSK, GSK.L) is to cut significantly the prices of its drugs in emerging economies next spring, according to a report in the Financial Times on Sunday. The reductions are expected to cut prices in most developing countries to below two-thirds of western prices and reflect intensified efforts by drug companies to capitalize on [...] Post from: (c)Autor: Forex Analytics FT: GlaxoSmithKline...
3Vote!
Forex Analytics (Free subscription) | 11/30/2009
GlaxoSmithKline PLC (GSK, GSK.L) is ton cuts significantly prices the off its drugs in emerging next economies to jump, according ton has report/ratio in one Sunday the of Financial Times. The reductions acres expected ton cuts prices in most developing ton below two-thirds off western countries and reflect intensified efforts by drug ton one capitalize [...] Post from: (c)Autor: Forex Analytics FT:...
3Vote!
AboutLawsuits.com (Free subscription) | 11/25/2009
A batch of 170,000 doses of H1N1 vaccine manufactured by GlaxoSmithKline PLC has been placed on hold in Canada after reports surfaced of an unusually high number of severe allergic reactions to the swine flu vaccine. Health care professionals in Canada have been asked not to use the batch of vaccines, which only involve [...]
16Vote!
Pro-Life News (Free subscription) | 11/25/2009
Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to not use one batch of swine flu vaccines in case they trigger life-threatening allergies. Company spokeswoman Gwenan White said that they issued the advice after reports...
4Vote!
Reno Gazette Journal (Free subscription) | 11/24/2009
LONDON (AP) - Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients, but there are no similar reports from other countries, pharmaceuticals company GlaxoSmithKline PLC said Tuesday.
3Vote!
ProjectDisaster (Free subscription) | 11/24/2009
http://www.google.com/hostednews/ap/article/ALeqM5iAS-zirig_lx530YTbjBLdH5jAYQD9C5VH982 Small batch of swine flu vaccines pulled in Canada By MEERA SELVA (AP) LONDON — Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients, but there are no similar reports from other countries, pharmaceuticals company...
18Vote!
Seattle Times (Free subscription) | 11/24/2009
Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients, but there are no similar reports from other countries, pharmaceuticals company GlaxoSmithKline PLC said Tuesday.
3Vote!
Rocky Mount Telegram - Business (Free subscription) | 11/23/2009
TRENTON, N.J. — British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawin...
4Vote!
Miami Herald (Free subscription) | 11/23/2009
British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.
5Vote!
San Fransisco Chronicle (Free subscription) | 11/23/2009
British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer. The drug is already sold under the name Avodart, for treating symptoms of an enlarged prostate. The company was seeking... Cancer - Prostate cancer - Health - Conditions and Diseases - Prostate
5Vote!
MarketIntelligenceCenter.com (Free subscription) | 11/23/2009
GlaxoSmithKline PLC (NYSE: GSK) hit a new 52-Week high of $42.70 so far today. Currently the stock is up $1.12 (2.7%) to $42.65 on 852,101 shares traded. Today's high is up $15.50 from a 52-Week Low of $27.15. GlaxoSmithKline PLC stock has been showing support around $40.72 and resistance in the $41.96 range. Technic...
4Vote!
Avian Flu Diary (Free subscription) | 11/23/2009
# 4066 GlaxoSmithKline, makers of the Arepanrix vaccine, have ordered doctors to hold off giving any more doses from one particular batch while the company investigates a higher than normal number of allergic reactions. The number of doses on hold are about 170,000 – a fraction of the 7.5 million doses already delivered to Canada. Six cases of anaphylaxis from this batch were reported in Manitoba,...
2Vote!
tamilselvan1 | 08/16/2009
Drugmaker GlaxoSmithKline PLC said Friday it has started testing its swine flu vaccine in humans. Glaxo said it plans to conduct 16 clinical trials of its swine flu vaccine in more than 9,000 people in Europe and North America.
1Vote!
aarkstore | 08/05/2009
Introduction This databook is a detailed information resource covering all the key data points on Oral hygiene in South Africa. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2007 and full forecasts to 2012. Scope * Contains information on 5 categories: Toothpaste, Toothbrushes, Mouthwash, Dental floss and Denture care * Provides market...
2Vote!
aarkstore | 08/05/2009
Introduction This databook is a detailed information resource covering all the key data points on Oral hygiene in Finland. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2007 and full forecasts to 2012. Scope * Contains information on 5 categories: Toothpaste, Toothbrushes, Mouthwash, Dental floss and Denture care * Provides market value,...
Videos